Target intelligence / Profile preview

Fungal fatty acid synthase (FAS)

Target
FAS
Molecular classification
Enzyme, Multienzyme complex, Transferase, Oxidoreductase
01

Overview

Fungal fatty acid synthase (FAS) is a massive multienzyme complex responsible for the de novo synthesis of long-chain fatty acids, which are essential components of fungal cell membranes and signaling molecules. Unlike the individual enzymes found in bacteria (Type II FAS) or the single-polypeptide chain found in mammals, fungal FAS is a 2.6 MDa alpha6-beta6 heterododecameric complex that encapsulates all necessary catalytic activities within a protected reaction chamber (PMID: 17431170, 28439016). This structural divergence from human FAS makes it a highly attractive target for the development of narrow-spectrum antifungal agents. Inhibition of this complex leads to the depletion of essential lipids, resulting in loss of membrane integrity, growth arrest, and eventual cell death (PMID: 31603670). While several inhibitors like cerulenin have demonstrated potent antifungal activity in vitro, therapeutic application has been limited by toxicity and poor stability, driving ongoing research into more selective, non-covalent inhibitors (PMID: 25108033).

Other names
Fungal fatty acid synthase complexFatty acid synthetaseType I fungal fatty acid synthaseFAS1/FAS2 complex
02

Mechanism of action

Inhibition of the ketoacyl-synthase (KS) domain or other catalytic subunits within the multienzyme complex, preventing the condensation of acetyl-CoA and malonyl-CoA into long-chain fatty acids.

03

Biological functions

De novo fatty acid biosynthesisLipid metabolismCell membrane synthesisEnergy storageProduction of palmitic acid
04

Disease associations

InfectionCandidiasisAspergillosisCryptococcosisSystemic fungal infections
05

Safety considerations

Cross-reactivity with human Fatty Acid SynthasePotential hepatotoxicityMetabolic interference in host lipid processingPoor pharmacological properties of early-stage inhibitors (e.g., cerulenin)
06

Interacting drugs

Cerulenin

4 more in the full profile.

07

Biomarkers

Fungal load reductionMalonyl-CoA accumulationPalmitic acid levelsErgosterol biosynthesis intermediates

Beyond the preview

Go deeper on Fungal fatty acid synthase (FAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal fatty acid synthase (FAS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call